Skip to main content

Table 2 Demographics and clinical characteristics between primary open-angle glaucomatous participants and participants without neuropathy in the Montrachet study

From: Plasma fatty acids and primary open-angle glaucoma in the elderly: the Montrachet population-based study

Baseline characteristics

Total

n = 810

Participants without neuropathy

n = 742

Participants with Primary open-angle glaucoma

n = 68

P

Age, years

82.11 ± 3.67

81.99 ± 3.62

83.36 ± 4.07

0.003

Sex

 Male

292 (36.05)

266 (35.85)

26 (38.24)

0.695

Smoking status, yes, n = 96

282 (35.43)

257 (35.16)

25 (38.46)

0.594

Alcohol consumption, yes, n = 730

46 (6.30)

44 (6.58)

2 (3.28)

0.312

Body mass index, > 25 kg/m2

379 (46.79)

348 (46.90)

31 (45.59)

0.836

Diabetes, n = 729

66 (9.05)

58 (8.68)

8 (13.11)

0.248

Diabetic retinopathy

7 (0.86)

7 (0.94)

0 (0.00)

 

Age-related maculopathy degeneration (AMD) stage, n = 753

   

0.530

 No AMD

412 (54.71)

381 (55.14)

31 (50.00)

 

 Early AMD stage 1

235 (31.21)

213 (30.82)

22 (35.48)

 

 Early AMD stage 2

78 (10.36)

71 (10.27)

7 (11.29)

 

 Early AMD stage 3

15 (1.99)

15 (2.17)

0 (0.00)

 

 Late AMD

13 (1.73)

11 (1.59)

2 (3.23)

 

Intraocular pressure, mmHg

15.49 ± 3.32

15.46 ± 3.32

15.81 ± 3.35

0.407

Cup/Disc Ratio, n = 780

0.36 ± 0.22

0.32 ± 0.19

0.74 ± 0.09

< 0.0001

Mean deviation of visual field, dB, n = 783

−11.69 ± 8.12

NA

−11.69 ± 8.12

NA

Axial length, μm, n = 664

23.44 ± 1.30

23.39 ± 1.24

23.88 ± 1.77

0.006

Antihypertensive treatment, n = 730

442 (60.55)

400 (59.79)

42 (68.85)

0.166

Lipid lowering drug use, n = 730

331 (42.60)

283 (42.30)

28 (45.90)

0.586

Plasma total cholesterol, mmol/l

5.80 ± 0.96

5.81 ± 0.97

5.82 ± 0.75

0.921

Low density lipoprotein, mmol/l

3.61 ± 0.84

3.60 ± 0.86

3.65 ± 0.69

0.650

High density lipoprotein, mmol/l

1.67 ± 0.40

1.67 ± 0.39

1.64 ± 0.43

0.567

Triglycerides, mmol/l

1.17 ± 0.50

1.17 ± 0.51

1.15 ± 0.43

0.781

  1. P value was calculated between participants without neuropathy and participants with primary open-angle glaucoma
  2. The results are displayed as n (%) for categorical variables and mean ± standard deviation for continuous variables